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ABSTRACT 
 
 Microperimetry (MP) is a technology that allows the study of retinal sensitivity 
at different foveal and parafoveal areas as well as eye fixation. It is a technique of 
functional evaluation, providing a direct correlation between anatomical and functional 
outcomes. There are a great variety of studies published not only evaluating the 
repeatability or reliability of measurements obtained with this technology but also 
describing and exploring different clinical applications. MP has been shown to be useful 
in the characterization of sensory and motor conditions, such as amblyopia or 
nystagmus. Concerning ocular pathology, different studies have confirmed the 
usefulness of MP for evaluating and analysing different retinal pathological conditions, 
such as age-related macular degeneration or glaucoma, and to analyze the effect of 
different medical or surgical treatments for these conditions. MP has been also shown to 
be useful for visual training or rehabilitation in some specific cases.  
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INTRODUCTION 
 
 Microperimetry (MP) is a technique that allows us to analyse different parts of 
the retina and simultaneously to assess how they respond to light stimuli, combining the 
anatomical and functional assessment of the retina in a same instrument.1-3 MP allows 
the clinician to visualize the retina of the patient with an optical illumination system that 
projects light to the retina and a camera capturing an image which can be recorded by 
means of different software systems in a similar manner as other techniques of 
exploration of the eye fundus (Figure 1A). Likewise, a microperimeter projects light 
stimuli of different intensities to the retina to assess the sensitivity of each region and 
records the patient's responses to these stimuli, as other techniques of automated 
perimetry (Figure 1B). MP does not differ greatly from other techniques of 
ophthalmoscopy or perimetry, but provides the unique feature of allowing the 
performance of both exams in a single measurement, integrating both viewing and 
projection systems in a single instrument (Figure 1C). 
 Since the release of the first microperimeter, the SLO (Rodenstock),4 the 
technique has maintained the same principles but has technologically evolved into more 
sophisticated models that are currently available, such as the MP1 (Nidek),5,6 the 
OCT/SLO (Optos)7 and the more recent of them, the MAIA system (Centervue).8 The 
present review describes the main clinical applications of MP considering the scientific 
evidence reported in the last years. The applications of sensitivity and eye fixation 
evaluation with MP have been revised, with analysis of the specific uses in different 
conditions and diseases. 
 
 
 
SENSITIVITY EXAM 
 
Anatomical-functional correlation 
 The ability to locate the patient functional deficits in its own retina has been a 
breakthrough in the study of eye diseases. The last microperimeters even incorporate the 
possibility of correlating sensitivity with tomographic findings, either in a single 
acquisition, as the OCT/SLO system, or after acquiring both examinations separately 
and overlapping them later using specific software, as the MP1 and MAIA systems. 
Another advantage that provides MP with respect to other functional techniques is that 
although the size of the stimuli that are projected on the retina of the patient is the same 
compared to conventional perimetry, the region evaluated is much smaller, allowing the 
clinician to better examine in detail one specific region of the retina due to the shorter 
distance between stimulus.  
 
Control of fixation losses 
 MP offers the correction of subject eye movements to generate an accurate 
projection of the light stimuli in the specific region that is going to be examined. This is 
possible due to the use of eye trackers. These eye trackers detect the position of the 
retina using as references some anatomical features, such as the position of a vessel or 
the size of the optic nerve, and generate automatically a recalculation of the new 
position where the light stimulus must be projected when there is a shift of the position 
of the reference image. This guarantees a correct projection of stimuli on the retina of 
the patient, being independent from fixation losses occurring during the test and 
therefore providing more reliable results. 
 
Follow-up 
 The correct follow-up of a condition along different sessions is a consequence of 
the two previous characteristics: the measurement of the correlation between patient’s 
retina and its sensitivity, and the confidence that this correlation analysis is good and 
reliable due to the control of fixation losses. Regarding the use of MP of follow-up, the 
instrument projects light stimuli in the same regions of the retina than in the previous 
visits, allowing the comparison of the variation in the results point-by-point. 
 
FIXATION EXAM 
 Another important feature provided by MP is the possibility of studying the 
fixation of the patient in a form never studied with any other technique. During 
examination, eye trackers correct fixation losses of the patient by registration of eye 
movements, but at the same time these records provide us information of how is the eye 
fixating. In other words, MP allows the clinician to evaluate the stability and position of 
the fixation. 
 
Fixation stability 
 The control of fixation losses provides an indirect measure of the position of the 
retina and their movements during the performance of the exam. This measure, which 
was initially used for obtaining more reliable perimeter examinations, provides valuable 
information about the ability of the subject to keep the eyes fixating at a point, and 
therefore about the stability of fixation. Fixation stability analysis can be done using 
two parameters, indexes P1 and P2, which indicates the percentage of points that are 
inside of a circle of 1 ° and 2 ° of radius, respectively, or by using the Bivariate Contour 
Ellipse Area (BCEA), which represents the area of an ellipse which contains all points 
of fixation (Figure 2). 
 
Position of fixation 
 The stability of fixation provides information on how stable or unstable is the 
eye position during the test, but also, depending on the region of retina that use the 
subject to focus his gaze, named as Preferred Retinal Locus (PRL), the clinician can 
detect if there is a central (when the PRL is foveolar) or eccentric (when using another 
region) eye fixation. 
 
Visual rehabilitation 
 Visual rehabilitation through training of fixation is another innovation that 
incorporates MP. This consists on the use of acoustic signals to re-educate subject’s 
fixation while looking at a fixating point with the MP device. This rehabilitation can be 
done in the same position of its PRL with the objective of working its stability or in 
another position of the retina when the objective is to create a new PRL with better 
sensory conditions.  
 
CLINICAL APPLICATIONS 
 
Sensory and motor conditions 
 MP was focused some years ago almost exclusively on the study of macular 
pathology and low vision, but in the most recent years more studies are being published 
showing the application of MP in other fields, such as binocular vision and evaluation 
of oculomotor problems.  
Amblyopia 
 Regardless of whether amblyopia is due to sensory or motor deficits, the 
possibility of evaluating retinal sensitivity and fixation with MP, makes this technology 
useful for the evaluation of amblyopia. There is not only a decrease in the retinal 
sensitivity of the amblyopic eye that can be detected with MP, this instrument also 
allows the clinician to detect small central asymptomatic scotomas that are hardly 
detectable with other techniques.9,10 
 The study of fixation in subjects with amblyopia by means of MP has been 
reported in the peer-reviewed literature for both strabismic or anisometropic 
amblyopia.10,11 Regarding the fixation pattern of the amblyopic and dominant eye, some 
authors have reported significant differences but only for subjects with strabismic 
amblyopia.11 Likewise, the study of the eye fixation has been also used to correlate its 
stability and position with other clinical parameters, such as best corrected visual acuity 
(BCVA),9-11 stereopsis,11 or  magnitude of strabismus.10 
 
Nystagmus 
 Methods of recording ocular movements can be divided into 
electrophysiological methods, based on the analysis of bioelectrical properties of the 
eye, oculographic methods, based on the physical registration of eye positions over 
time, and other video eye trackers based on other different technologies. MP belongs to 
the second group with the advantage that allows the registration of eye movements 
directly on retinal image. For this reason, some authors have seen in MP an opportunity 
for the study of eye movements in nystagmus.12-14 Our research group was the first that 
proposed the use of MP as an objective method of quantification of the nystagmic 
movement and characterization of fixation pattern in comparison to the video-
oculography.12 Subsequently, we studied the fixation through MP in a group of subjects 
with nystagmus of different etiology with the objective of characterizing the different 
fixation patterns that can be present in this type of oculomotor condition.13 A significant 
correlation was found in this study between retinal sensitivity and BCVA as well as 
between stability of fixation and BCVA.13 In addition to studies related to subjects with 
nystagmus, other authors have studied the nystagmic movements associated with other 
conditions as is the case of oculocutaneous albinism,15,16 even showing the possibility of 
fixation training in these subjects using MP.16 It should be considered that although MP 
allows a characterization of fixation movements, MP software is not yet designed to 
extract the periodic aspects of nystagmus, as can be done with video-oculography 
system. MP allows us to characterize the movement directly on retina, but further 
studies are still needed to develop future applications for a more precise analysis of 
nystagmic movements. 
 
Ocular pathology 
 MP is an instrument that has been mainly used to evaluate the impact on the 
visual function of different ocular pathologies or to monitor the follow-up of these 
pathological conditions. The usefulness of MP for the characterization of the eye 
fixation in pathological subjects has been also demonstrated in studies evaluating the 
fixation stability, the central or eccentric position of the PRLs, or the correlation 
between fixation and other clinical parameters, such as visual acuity, retinal anatomy or 
contrast sensitivity. In the following lines, we describe the clinical application of MP in 
some pathological conditions according to the peer-reviewed literature of the last years. 
 
 
Age-related macular degeneration 
 MP has shown its utility in age-related macular degeneration (AMD). AMD has 
been studied by MP with different objectives: correlation of anatomical findings with 
functional deficits,17-19 follow-up of the pathology over time,20,21 pre and post-medical 
control22,23 or control of a surgical treatment,24,25 the study of eye fixation,26,27 and 
performance of visual rehabilitation programs.28 The possibility of correlating the 
anatomical and functional findings with MP has allowed the clinician to assess the level 
of loss of retinal sensitivity associated to different structural damages and to know 
which retinal layers generate a more significant damage on the visual function. Several 
authors have studied the relationship between retinal sensitivity and the thickness of 
various layers, such as the retinal pigment epithelium (RPE) or the outer segment of 
photoreceptors.18,19 Other authors have also studied the fixation depending on the stage 
of the disease. Although these authors have found a direct correlation between the initial 
and intermediate phases of AMD and sensitivity, no correlation has been observed 
between AMD stage and fixation.17  
 Regarding the follow-up of AMD, some authors have recommended to perform 
a first measure of training before the definitive measurement as significant differences 
in intrasession test-retest variability is present in subjects with AMD20 in contrast to 
normal subjects.8 After the baseline examination, several authors have analysed longer 
variations in MP outcomes in order to assess whether the technique is useful for the 
monitoring of the evolution of the disease, with a significant sensitivity loss during one 
year of evolution,21,22 without BCVA changes associated.20 In the case of fixation, no 
significant differences in the evolution of the pathology during a 1-year follow-up have 
been detected.21 More studies are needed to confirm this trend in a longer term.   
 An accurate sensitivity measure with MP may allow a precise correlation over 
time between examinations, with the potential of being useful in the control of 
anatomical changes that may occur as a consequence of the evolution of the pathology, 
as mentioned before, or after medical22,23 or surgical treatments.24,25 Some authors have 
studied by MP the improvements in retinal sensitivity produced after medical treatment, 
as for example, in the case of intravitreal anti–vascular endothelial growth factor (anti-
VEGF) therapy22 or after long term prescription of supplementation of lutein and 
zeaxanthin.23 In the case of surgical treatments, MP has also demonstrated its usefulness 
for comparisons pre and post-surgery,24 and in some cases for the long term follow-up 
of the results of different surgical techniques, such as the autologous translocation of 
choroid and retinal pigment epithelium.25 
 The study of fixation in AMD has been based, as in other pathologies that affect 
central vision, not only in the study of stability but also in centrality.27,29,49 In the case of 
stability, this has been studied by means of the BCEA, correlating the instability of the 
fixation with the further evolution of the pathology26 or the lower speed of reading.29 
The identification of PRLs and their eccentricity from the fovea will determine, 
combined with the study of BCVA, the region of the retina that is the most suitable for 
observation by the patient.27 Also, if the patient has not developed an optimal PRL by 
himself, visual training module allow patients to locate and train that region with greater 
functional possibilities.28 
 Most of studies agree in the statement that the structural damage precedes the 
loss of BCVA, and evidence that the evaluation of visual acuity in AMD is not enough 
to assess the visual function affectation, being necessary an additional functional 
testing. In this way, MP is very useful because it can detect these small losses of 
functionality that are present in the early stages of AMD.17,18,20   
Diabetes 
 Besides AMD, diabetes is the most studied pathology by MP, probably due to its 
significant incidence in the general population, but also because MP provides a 
comprehensive and precise examination of sensitivity in diabetic vascular problems. 
Different MP applications have been described in the peer-reviewed literature for 
diabetic patients, such as the characterization of anatomical and functional changes,30-34 
comparison of pre and post-medical or surgical treatment,35-41 or the study of eye 
fixation.30,42 The characterization of anatomical and functional changes in diabetes 
through MP differs from the study of sensitivity losses caused by ischemia due to 
capillary drop-off,30 the loss of sensitivity in macular-induced diabetic edema,31,32 or the 
study of anatomical alterations as microcysts32,33 or hard exudates.32,34 
 There are multiple medical treatments for diabetic retinopathy. Some of them 
have been analysed by MP in order to evaluate the changes before and after their 
prescription, such as flavonoids and vitamins,35,36 anti-VEGF injections,37,38 or 
dexamethasone implants,39 as well as to evaluate the follow-up of the effect of these 
treatments over time.35,39 MP has been also used to study some surgical treatments, such 
as pan-retinal laser photocoagulation, with the objective of quantifying the reduction on 
sensitivity40 and  to compare several of them.37,41 
 Regarding the stability and location of fixation, a correlation between the 
stability of fixation and other parameters, such as BCVA,30,42 the presence of central 
scotomas,42 or anatomical findings has been detected.42 Also, the correlation between 
the location of fixation and anatomical findings has been studied42 as well as the 
relationship between fixation stability and PRL location.42 
 
 
Macular hole 
 Macular hole (MH) is the third pathological condition with more studies using 
MP as it is a pathology in which an exact correlation between functionality and anatomy 
is almost indispensable for clinicians and practitioners. There are many studies on the 
correlation of anatomy and functionality, such as those studying the relation between 
sensitivity and depth of the hole43 or the integrity of the different layers of the retina as 
the external limiting membrane44 or the photoreceptors.43,44 Most of studies with MP in 
MH are focused on assessing the patient’s characteristics prior to surgery. Specifically, 
there are studies aimed at predicting the surgical results of MH,45,46 comparing the 
sensitivity and fixation improvements before and after surgery,47 or comparing the 
results with different surgical techniques.48 Also, the possibility of visual rehabilitation 
by means of MP has been studied following surgery in MH to improve the results of 
BCVA.49 
 
Central serous corioretinopathy (CSC) 
 Authors have mainly studied the anatomical-functional correlation in CSC 
(retinal thickness/sensitivity), relating those regions with loss of the ellipsoid portion of 
the inner segments with decreased sensitivity50 or studying the concordance between 
angiography and the sensitivity obtained through MP.51 Concerning the treatment of 
CSC, MP provide the clinician information about results obtained by photodynamic 
therapy through the analysis of pre and post-surgical sensitivity,52 or about which 
technique provides the best results in terms of sensitivity in CSC patients.53,54 
 
 
 
Glaucoma 
 Glaucoma is a condition that mainly affects peripheral vision and only it is 
perceived by patient in the more advanced stages, when the central or paracentral vision 
is affected. Conventional perimetry has become the gold standard technique in the 
detection of the glaucomatous damage, but MP can also be a valuable tool in the 
assessment of glaucomatous patients. There are different studies comparing MP and 
conventional perimetry outcomes that reveal that MP seems to be more sensitive in 
predicting glaucomatous visual field loss.55 Some authors suggest that this is because 
the measure of the macular thickness is also comparable to the quantification of the 
glaucomatous damage of the peripapillary nerve fiber layer.56 Therefore, if changes in 
macular structure correlate with functional alterations,57,58 the measure of functional 
deficits at the macular level may also reflect the glaucomatous damage.56 There are 
some studies on the use of MP in patients with glaucoma with different purposes: to 
correlate the anatomy with the functionality,57,58 to analyse the differences between 
open-angle and close-angle type glaucoma,56 to compare the results with conventional 
perimetry,55,57 to study the fixation pattern,59 and to evaluate of potential of 
rehabilitation with MP through biofeedback.59,60 
 
Rod-cone alterations 
 In rod and cone dystrophies and degenerations, which are pathologies affecting 
directly photoreceptors, functional techniques are very useful in measuring the light 
response because deficiency can be determined according to the decrease in the answers 
of patients. In this sense, MP does not seem to have much to contribute to the rest of the 
studies carried out with conventional perimetry, but it has the advantage of correlating 
sensitivity losses with anatomical changes. 
Stargardt disease 
 Stargardt disease is a degenerative disease that affects the photoreceptors of the 
macula. MP is very useful in this pathological condition because it can characterize the 
macular damage through the loss of retinal sensitivity, and correlate it with anatomical 
findings.61,62 Likewise, MP is a valuable technique for the study and monitoring of 
Stargardt disease over years.61 MP has also shown its utility in the study of the fixation 
of subjects with Stargardt,61,62 with some studies even showing the potentiality of visual 
rehabilitation with MP through fixation training.63 
  
Retinitis pigmentosa 
 Retinitis pigmentosa (RP) comprises a group of retinal dystrophies with different 
clinical signs that primarily affect the rods, but also with some involvement of cones. 
While classically RP is a pathology that affects to the middle retinal periphery, this 
pathological condition continues its expansion towards the central region, generating a 
small central island of vision in its more advanced phases. MP is very useful to quantify 
this remaining central visual field as visual acuity can be preserved,64 but it is 
insufficient to quantify the true deficit of RP patients. A more functional analysis, as the 
measure of retinal sensitivity, is needed to assess the progress of the pathology.64 
 
Epiretinal membrane 
 The epiretinal membrane (MER) or macular pucker is a growth of tissue in the 
vitreoretinal interface that can cause macular damage due to the traction that generates 
on the retinal surface. It usually occurs near or in the macula, causing the presence of 
metamorphopsias as well as a decrease in BCVA. However, BCVA is not a reliable 
indicator of the impairment of visual function, because MERs are composed of 
translucent tissue that also produces a decrease in contrast sensitivity.65 MER treatment 
is surgical and has the associated risk of producing central scotomas caused by retinal 
traction during the intervention. MP is an ideal instrument for the characterization of the 
visual functional changes in MER, as it does not only assess the visual loss prior to 
surgery,65 but also it allows the clinician to perform a detailed comparative analysis pre 
and post-surgery,66 an analysis subsequent to the intervention,67 and a control and 
monitoring of results over time.66,67 The majority of studies with MP are based on the 
analysis of the outcomes of the surgical treatment of MER, although some authors have 
also studied the fixation pattern in subjects with MER.68 
 
Toxicity 
 MP has been a breakthrough in the characterization of macular pathologies that 
affect to a very specific retinal areas, such as toxic maculopathies induced as a side 
effect of different medications prescribed for the treatment of systemic diseases. These 
toxic alterations sometimes remain unnoticed and undetectable by other techniques such 
as conventional perimetry.69 It is the case of chloroquine and hydroxychloroquine 
maculopathies69,70 induced by medications used for the treatment of rheumatoid arthritis 
or lupus, or deferoxamine maculopathy,71 an agent used to treat systemic iron overload. 
Besides these toxic effects, there are other substances that are used in surgical 
procedures and that produce toxicity of retinal tissues, such as perfluorocarbon liquid72 
or brilliant blue G.73 
  
 
 
 
Conclusions 
 MP is a technique that allows to correlate retinal anatomical findings and 
functional outcomes as well as to study the eye fixation of a patient. Therefore, it is a 
crucial tool for evaluating and understanding the causes of functional loss in different 
retinal conditions. Furthermore, MP allows the clinician to understand how the patient 
is using the macular area for his/her vision, with the possibility of characterizing the 
pattern of fixation and even to train the fixation to improve the visual acuity and 
binocular vision. There are a very extensive peer-reviewed literature demonstrating the 
clinical applications of MP in the study of sensory and motor conditions, such as 
amblyopia or nystagmus, as well as in the evaluation of different ocular pathologies, 
such as ARMD, diabetic retinopathy, MH or toxic retinopathies and the effect of 
different therapeutic approaches for their treatment. More studies are still needed to 
define more future potential applications of this technology as well as to develop the 
potential of MP as a tool for visual rehabilitation and training. 
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FIGURE LEGENDS 
 
Figure 1.- Fundus image obtained with SLO from left eye of a normal subject (A); 
Sensitivity exam from left eye of a normal subject (B); both sensitivity exam and fundus 
image obtained with SLO from left eye of a normal subject (C). All images were 
obtained from the same patient with MAIA microperimeter (Centervue). 
 
 
 
Figure 2.- Fixation exam obtained from a normal subject with stable fixation obtained 
with the MAIA microperimeter from Centervue. Blue points represent all the positions, 
fixation points of the patient’s eye during the examination. Purple ellipses represent 
Bivariate Contour Ellipse Areas (BCEA) with 95% of SD (standard deviation) and 63% 
of SD. Total area for each SD, horizontal and vertical diameter (H° x V°) in degrees of 
those ellipses and the angle of orientation are shown.  
 
  
